3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
5
FED
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Classical hematology
1
Conditions
Prostatic Neoplasms
53
Neoplasms
8
Urinary Bladder Neoplasms
4
Neoplasm Metastasis
4
Urinary Incontinence
3
Erectile Dysfunction
3
Pulmonary Disease, Chronic Obstructive
2
Non-Muscle Invasive Bladder Neoplasms
2
Lung Neoplasms
2
Kidney Failure, Chronic
2
Heart Failure
2
Dementia
2
Breast Neoplasms
2
Weight Loss
1
Urogenital Neoplasms
1
Ureteral Neoplasms
1
Turcot syndrome
1
Recurrence
1
Prostatic Neoplasms, Castration-Resistant
1
Prostatic Diseases
1
Prostate cancer, familial
1
Prostate Cancer Prevention
1
Prostate Cancer Diagnosis
1
Patients With Prostate Cancer
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Obesity
1
Newly Diagnosed Oligometastatic Prostate Cancer
1
Neoplasms by Site
1
Motor Activity
1
Male Urogenital Diseases
1
Interventions
olaparib
1
Carboplatin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
FED
×
Hereditary Sensory and Autonomic Neuropathies
×
Genitourinary
×
Clear all
NCT04038502
2025-08-20
COBRA
VA Office of Research and Development
Phase 2
Recruiting
100 enrolled